Ultragenyx clinical development technology leadership across endpoint strategy, protocol feasibility, digital operations, and live trial execution.
Kevin worked inside Global Development Operations under an SVP reporting to the CMO, served on the Operations Leadership Team and Strategic Leadership Team, and represented technology feasibility on Protocol Development Teams.
Operations Leadership Team and Strategic Leadership Team
Served in clinical development operating leadership forums, connecting technology strategy to Global Development Operations priorities.
Protocol Development Team representation
Represented technology feasibility in relation to endpoint strategy, operational risk identification and mitigation, patient-centered UI/UX, and practical study execution.
Wearables and CGM SME
Served as company SME for wearables, especially continuous glucose monitoring, across multiple programs including gene therapy and metabolic disease.
Endpoint and operational feasibility
Helped teams understand when digital endpoints, wearable data, connected devices, and patient-facing workflows could support study objectives without creating avoidable operational risk.
Patient-centered UI/UX
Brought patient-centered design thinking into protocol and technology discussions, focusing on real-world use, burden reduction, comprehension, and workflow fit.
Bridge to delivery
The same role connected strategy to execution through the Innovation Lab, Rarify, third-party EDC/mobile app support, device logistics, QA, and clinical operations delivery.
Request access to selected supporting materials
Selected summaries and supporting materials may be available for appropriate professional discussions.